Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure

Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure

Abstract Aims Diabetes mellitus is associated with worse outcomes and lower attainment of disease‐modifying therapies in patients with heart failure with reduced ejection fraction (HFrEF). This post hoc analysis of TRANSITION compared the patterns of tolerability and uptitration of sacubitril/valsar...

Full description

Bibliographic Details
Main Authors: Klaus K. Witte, Rolf Wachter, Michele Senni, Jan Belohlavek, Ewa Straburzynska‐Migaj, Candida Fonseca, Eva Lonn, Adele Noè, Heike Schwende, Dmytro Butylin, YannTong Chiang, Domingo Pascual‐Figal, the TRANSITION investigators
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:ESC Heart Failure
Subjects:
Acute decompensated heart failure
Angiotensin receptor neprilysin inhibitor
Diabetes mellitus
Heart failure with reduced ejection fraction
N‐terminal‐pro‐B‐type natriuretic peptide
Sacubitril/valsartan
Online Access:https://doi.org/10.1002/ehf2.14166

Internet

https://doi.org/10.1002/ehf2.14166

Similar Items